Impact of left ventricular ejection fraction on occurrence of ventricular events in defibrillator patients with coronary artery disease

Europace

Volumn 13, Issue 11, 2011, Pages 1562-1567

  Schaer, Beat ^a,b   Sticherling, Christian ^a   Szili Torok, Tamas ^b   Osswald, Stefan ^a   Jordaens, Luc ^b   Theuns, Dominic A ^b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Coronary artery disease; Implantable cardioverter defibrillator; Left ventricular ejection fraction; Primary prevention of sudden cardiac death

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEFIBRILLATOR; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIMARY PREVENTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SUDDEN DEATH;

AGED; ATRIAL FIBRILLATION; CORONARY ARTERY DISEASE; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PRIMARY PREVENTION; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE VOLUME; TACHYCARDIA, SINUS; TACHYCARDIA, SUPRAVENTRICULAR; VENTRICULAR DYSFUNCTION, LEFT;

EID: 80054906384     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eur169     Document Type: Article

References (11)

1. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS et al. Multicenter Automatic Defibrillator Implantation Trial II Investigators: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83. (Pubitemid 34984635)
2. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R et al. Sudden Cardiac Death in Heart Failure (SCD-HeFT) Investigators: Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352: 225-37. (Pubitemid 40110811)
3. Epstein AE, Dimarco JP, Ellenbogen KA, Estes NA III, Freedman RA, Gettes LS et al. American College of Cardiology/American Heart Association Task Force on Practice; American Association for Thoracic Surgery; Society of Thoracic Surgeons. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: Executive summary. Heart Rhythm 2008;5:934-55.
4. Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R et al. on behalf of the DINAMIT investigators: Prophylactic use of an implantable cardioverterdefibrillator after acute myocardial infarction. N Engl J Med 2004;351:2481-8. (Pubitemid 39603155)
5. Alsheikh-Ali AA, Homer M, Maddukuri PV, Kalsmith B, Estes M, Link MS. Timedependence of appropriate implantable defibrillator therapy in patients with ischemic cardiomyopathy. J Cardiovasc Electrophysiol 2008;19:784-9. (Pubitemid 352036648)
6. Gasparini M, Menozzi C, Proclemer A, Landolina M, Iacopino S, Carboni A et al. A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary prevention: The RELEVANT [Role of long dEtection window programming in patients with LEft VENTRICULAR dysfunction, non-ischemic eTiology in primary prevention treated with a biventricular ICD] study. Eur Heart J 2009;30:2758-67.
7. Wilkoff BL, Williamson BD, Stern RS, Moore SL, Lu F, Lee SW et al. PREPARE Study Investigators: Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: Results from the PREPARE (Primary Prevention Parameters Evaluation) study. J Am Coll Cardiol 2008;52:541-50.
8. Santini M, Russo M, Botto G, Lunati M, Proclemer A, Schmidt B et al. Clinical and arrhythmic outcomes after implantation of a defibrillator for primary prevention of sudden death in patients with post-myocardial infarction cardiomyopathy: The Survey to Evaluate Arrhythmia Rate in High-risk MI patients (SEARCH-MI). Europace 2009;11:476-82.
9. Sweeney MO, Wathen MS, Volosin K, Abdalla I, DeGroot PJ, Otterness MF et al. Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: Results from the pacing fast VT reduces shock therapies (PainFREE Rx II) trial. Circulation 2005;111:2898-905. (Pubitemid 40814182)
10. Goldenberg I, Vyas AK, Hall WJ, Moss AJ, Wang H, He H et al. for the MADIT-II Investigators: Risk stratification for primary implantation of a cardioverterdefibrillator in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol 2008;51:288-96.
11. Singh JP, Hall WJ, McNitt S, Wang H, Daubert JP, Zareba W et al. and the MADIT-II Investigators. Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation. J Am Coll Cardiol 2005;46: 1712-20. (Pubitemid 41531628)